Onconetix Inc (ONCO)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$0.55

-0.00 (-0.02%)

Market Cap: $2.92M

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Performance (10Y)

Beat Rate

29%(2/7)

Avg Surprise

-377249.24%

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Jun 30, 2026Jun 26 Reported Aug 13, 2026Reported Aug 13	$-1.28	N/A	-	N/A	Beat	-	-	+69.4%
Mar 31, 2026Mar 26 Reported May 13, 2026Reported May 13	$0.00	$0.00	-	N/A	Beat	-	-	+100.0%
Dec 31, 2025Dec 25 Reported Mar 12, 2026Reported Mar 12	$0.00	$0.00	-	N/A	Beat	-	-	+100.0%
Sep 30, 2025Sep 25 Reported Nov 13, 2025Reported Nov 13	$-6.25	$0.00	-	N/A	Miss	-	-	+97.5%
Jun 30, 2025Jun 25 Reported Aug 14, 2025Reported Aug 14	$-4.18	$0.00	-	N/A	Miss	-	-	+99.8%
Mar 31, 2025Mar 25 Reported Jun 2, 2025Reported Jun 2	$-45.44	N/A	-	N/A	Beat	-	-	-8951.8%
Dec 31, 2024Dec 24 Reported Mar 6, 2025Reported Mar 6	$-2.93	N/A	-	N/A	Beat	0	No revisions (30d)	+99.9%
Sep 30, 2024Sep 24 Reported Dec 9, 2024Reported Dec 9	$-249.08	N/A	-	N/A	Beat	-	-	+99.5%
Jun 30, 2024Jun 24 Reported Aug 29, 2024Reported Aug 29	$-2191.49	N/A	-	N/A	Beat	-	-	-258.1%
Mar 31, 2024Mar 24 Reported Apr 11, 2024Reported Apr 11	$-0.50	$-0.21	$-0.21 - $-0.21	-139.05%	Miss	0	No revisions (30d)	+100.0%
Dec 31, 2023Dec 23 Reported Mar 7, 2024Reported Mar 7	$-3404.00	$-0.21	-	-1620854.67%	Miss	0	No revisions (30d)	-400.6%
Sep 30, 2023Sep 23 Reported Oct 20, 2023Reported Oct 20	$-52700.03	$-32300.02	-	-63.16%	Beat	-	-	-5640.7%
Jun 30, 2023Jun 23 Reported Aug 14, 2023Reported Aug 14	$-612.00	$-0.18	-	-339900.00%	Miss	-	-	-169900.0%
Mar 31, 2023Mar 23 Reported May 12, 2023Reported May 12	$-30600.02	$-34850.02	-	+12.20%	Beat	-	-	-8999905.9%
Dec 31, 2022Dec 22 Reported Mar 9, 2023Reported Mar 9	$-680.00	$-0.20	-	-339900.00%	Miss	-	-	-566566.7%
Sep 30, 2022Sep 22 Reported Nov 10, 2022Reported Nov 10	$-918.00	$-0.27	-	-339900.00%	Miss	-	-	-1835900.0%
Jun 30, 2022Jun 22 Reported Aug 15, 2022Reported Aug 15	$-0.36	N/A	-	N/A	Beat	-	-	-
Mar 31, 2022Mar 22 Reported Jun 29, 2022Reported Jun 29	$-0.34	N/A	-	N/A	Beat	-	-	-
Dec 31, 2021Dec 21 Reported Mar 30, 2022Reported Mar 30	$-0.12	$0.00	-	N/A	Miss	-	-	-
Sep 30, 2021Sep 21 Reported Nov 5, 2021Reported Nov 5	$-0.05	$0.00	-	N/A	Miss	-	-	-

Key Metrics

Valuation
P/E Ratio	-0.01	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	0.00%	Operating Margin	-13112.00%
ROE	-105.20%	ROIC	N/A
Financial Health
Debt/Equity	N/A	Interest Coverage	-31.79x
Current Ratio	2.21x	Quick Ratio	2.14x
Trading Statistics
Beta	2.61	Avg Volume	7.62M
52-Week High	$200.00	52-Week Low	$0.54

Technical Indicators Dashboard

Moving Averages

SMA 10$0.62

SMA 20$0.72

SMA 50$0.74

SMA 200$18.35

EMA 10$0.62

EMA 20$0.68

EMA 50$0.99

EMA 200$32.39

MACD

Line: -0.06Signal: -0.04Hist: -0.02

ADX

ADX: 23.3+DI: 32.4-DI: 22.7

Aroon & PSAR

Aroon Up44.0

Aroon Down100.0

PSAR$0.97

Bollinger Bands

Upper Band$1.04

Lower Band$0.40

%B Position8841%(Upper)

Band Width0.23

RSI (14-Day)

Neutral

38.3

Momentum Oscillators

Stoch %K1.8

Stoch %D2.6

Williams %R-98.2

ROC (10d)-26.4%

Momentum-0.20

CCI (20d)-95.3

MFI (14d)87.0

Volatility Measures

ATR (14d)$0.12(21.2%)

StdDev (20d)0.16

Hist Vol180.1%(High)

Volume Flow

VWAP$0.54

OBV1.0B

AD Line28909.5B

CMF (20d)-0.473

Volume Metrics

Avg Vol (20d)8.4M

Vol Ratio0.0x(Low)

VWMA (20d)$0.89

Pivot Points

R3$0.62

R2$0.60

R1$0.57

Pivot Point$0.56

S1$0.53

S2$0.51

S3$0.49

Advanced Oscillators

TSI-14.06

Ultimate Osc29.7

KST-90.26

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$17,120	$21,457	$303,596	$303,651	$106,494	$101,630	$711,976	$406,859	$704,848	$700,433	$58,465	$0
Cost of Revenue	$12,817	$23,112	$55,912	$34,757	$35,991	$55,798	$52,008	$301,445	$604,132	$511,433	N/A	$1,617
Gross Profit	$4,303	$-1,655	$247,684	$268,894	$70,503	$45,832	$659,968	$105,414	$100,716	$189,000	N/A	$-1,617

Operating Expenses	$2.74M	$2.09M	$1.53M	$2.34M	$1.41M	$1.70M	$2.68M	$2.75M	$13.72M	$11.27M	$7.42M	$4.49M
R&D	$3,440	$50,818	$24,293	$3,211	$111,670	$24,455	$290	$109,365	$3,680	$48,964	$198,921	$219,238
SG&A	$2.25M	$2.04M	$1.50M	$2.34M	$1.52M	$1.67M	$2.63M	$2.64M	$2.22M	$6.43M	$6.43M	$4.27M
Operating Income	$-2,730,790	$-2,091,800	$-1,281,367	$-2,069,242	$-1,341,418	$-1,652,829	$-1,972,082	$-2,645,867	$-13,615,019	$-11,081,990	$-7,361,307	$-4,488,083

Interest Income	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Interest Expense	$4,389	$2,244	$4,247	$300,069	$223,097	$223,592	$248,349	$384,958	$361,315	$413,056	$188,532	$269,097
Income Before Tax	$-2,867,303	$-4,214,875	$5.67M	$-8,783,702	$-2,372,442	$-8,545,885	$-30,356,339	$-3,883,789	$-14,255,936	$-11,240,139	$-22,363,465	$-5,346,908
Income Tax Expense	$0	$0	$525	$0	$0	$-917,997	$0	$-56,384	$50,768	$-121,567	$0	$269,097

Net Income	$-2,867,303	$-4,214,875	$5.67M	$-8,783,702	$-2,372,442	$-8,545,885	$-29,438,342	$-3,827,405	$-14,306,704	$-11,118,572	$-22,350,872	$-5,346,908

EBITDA	$-2,860,282	$-4,207,233	$5.68M	$-8,480,246	$-2,145,646	$-8,317,545	N/A	$-3,294,784	$-13,693,320	$-10,620,383	N/A	$-5,076,194
EBIT	$-2,862,914	$-4,212,631	$5.67M	$-8,483,633	$-2,149,345	$-8,322,293	N/A	$-3,498,829	$-13,894,621	$-10,827,083	N/A	$-5,077,811

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about ONCO

News

Why Realbotix Corp. (TSXV:XBOT) Is Planning a Nasdaq Listing for Its Humanoid Robotics Business Through an Onconetix Merger

Realbotix Corp. (TSXV:XBOT) is pursuing a Nasdaq Capital Market listing for its humanoid robotics and AI business through a reverse takeover with Onconetix, Inc. (NASDAQ...

kalkine.ca•Oct 14, 2026 5:41 AM ET10/14/26•Neutral

12 Health Care Stocks Moving In Thursday's Intraday Session

This article details the top gainers and losers among health care stocks during Thursday's intraday trading session. Pacira BioSciences, Onconetix, and Shuttle Pharmaceuticals were among the significant gainers...

Benzinga•Oct 8, 2026 3:11 PM ET10/8/26•Bullish

RBC Raises Price Target on Onconetix to $459 From $450, Keeps Outperform Rating

RBC Capital Markets has increased its price target for Onconetix (ONCO) from $450 to $459, while maintaining an "Outperform" rating on the stock. The adjustment reflects RBC's continued positive outlook...

marketscreener.com•Oct 8, 2026 7:32 AM ET10/8/26•Bullish

Five proposals face a November 10 vote as Onconetix (ONCO) asks for another reverse split.

Onconetix, Inc. is seeking stockholder approval for five proposals at its annual meeting on November 10, 2026. Key proposals include re-electing a director...

Stock Titan•Oct 7, 2026 3:11 PM ET10/7/26•Somewhat-Bearish

Onconetix’s Nasdaq Problem: Cash Burn Meets Share Dilution

Onconetix (NASDAQ: ONCO), a small-cap life-sciences company, has seen a 99% stock price drop over the past year due to severe dilution, "going concern" warnings...

Finimize•Oct 2, 2026 1:03 AM ET10/2/26•Bearish

ONCO Valuation and Fair Value

P/E: -0.0x
P/B: 0.1x

See GNG's fair value

ONCO Profitability: Margins, ROIC and FCF

Gross margin: 80.4%
Operating margin: -13112.0%
Net margin: 0.0%
ROE: -105.2%
FCF margin: -1596.1%

ONCO Competitors

Company	Ticker
Ridgetech, Inc.	RDGT
Bioatla Inc	BCAB
XORTX Therapeutics Inc	XRTX
Revelation Biosciences Inc	REVB
GRI Bio Inc.	GRI
Painreform Ltd	PRFX
Mustang Bio Inc	MBIO
HCW Biologics Inc	HCWB

Sector: Healthcare

ONCO Bull Case vs Bear Case

Bear case

ONCO beat EPS estimates in 0.0% of its last 8 reported quarters.
ONCO's quarterly revenue changed -83.9% year over year.

ONCO Earnings: Beat Rate and Next Report

Beat rate: 0 of 8 quarters (0.0%)
Average surprise: -101.1%

Frequently Asked Questions About ONCO

Does ONCO pay dividends?

Onconetix Inc (ONCO) does not currently pay a regular dividend.

What is ONCO's market cap?

Onconetix Inc (ONCO) has a market capitalization of $2.92M with a current stock price of $0.55.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In